SCHEMBL7568133

SCHEMBL7568133

O=C(Nc1ccccc1C(=O)O)C(=O)c1c(O)ccc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
MEN1 O00255 2/20 0.50
HPGD P15428 2/20 0.50
KMT2A Q03164 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 1/20 0.50
PTGER4 P35408 1/20 0.50
ALDH1A1 P00352 2/20 0.49
CDC25B P30305 3/20 0.49
GFER P55789 1/20 0.47
LDHA P00338 1/20 0.45
NR4A1 P22736 1/20 0.45
NR4A2 P43354 1/20 0.45
NR4A3 Q92570 1/20 0.45
NPC1 O15118 1/20 0.45
TP53 P04637 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
RAB9A P51151 1/20 0.45
HCAR2 Q8TDS4 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29946509 0.86 GFER (0.56) KDM4EMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL9290336 0.82 NPC1 (0.54) KDM4EMEN1HPGDKMT2ALMNA
Salicylic Acid SCHEMBL17712461 0.75 ALDH1A1 (0.60) KDM4EMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL4593816 0.74 CDC25B (0.61) KDM4EMEN1HPGDKMT2ASMN1; SMN2
SCHEMBL4268 0.74 ALDH1A1 (0.61) KDM4EMEN1HPGDKMT2AALDH1A1
SCHEMBL29376732 0.74 ALDH1A1 (0.61) KDM4EMEN1HPGDKMT2AALDH1A1
SCHEMBL29593799 0.74 ALDH1A1 (0.61) KDM4EMEN1HPGDKMT2AALDH1A1
SCHEMBL13936398 0.74 DHODH (0.64) KDM4EMEN1KMT2ALMNAALDH1A1
Phenol SCHEMBL27740227 0.73 ABCG2 (0.55) KDM4EMEN1HPGDKMT2AALDH1A1
SCHEMBL4959080 0.72 ALDH1A1 (0.59) KDM4EMEN1HPGDKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020035137-A1 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors ABBOTT LABORATORIES 2002-03-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035137-A1 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors PPM1A, PTPRO, PTP4A1 KDM4E 2015/4885MEN1 3065/4885HPGD 2547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.